Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 76 results for "aurobindo"

Market Update: Petronet, GAIL jumps 3-4%; SBI, PNB up close to 1%, Maruti, RIL most active
Money Control

Market Update: Petronet, GAIL jumps 3-4%; SBI, PNB up close to...

GAIL India which jumped over 4 percent and Tech Mahindra added 3 percent followed by Bosch, Aurobindo Pharma and Maruti Suzuki were the top Nifty gainers. Money Control, 1 week ago

73 images for aurobindo

Business Standard, 3 weeks ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 1 month ago
Sify, 1 month ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard

Higher volumes, launches help Aurobindo beat peers

While its peers continue to struggle with pricing and regulatory headwinds, Aurobindo Pharma's performance in the September quarter stood out, with operating and net profit growing at a strong 20-29 per cent, beating estimates. Growth across geographies and ...
 Business Standard1 month ago Aurobindo Pharma drops after announcing Q2 results  Business Standard1 month ago Aurobindo Pharma fixes record date for interim dividend  Business Standard1 month ago Aurobindo Pharma may gain on good Q2 results  Business Standard1 month ago
[x]  

Board of Aurobindo Pharma recommends interim dividend

First Published: Fri, November 10 2017. 16:26 IST RECOMMENDED FOR YOU RECOMMENDED FOR YOU
 Business Standard1 month ago Board of Aurobindo Pharma approves interim dividend of Rs 1.50 per share  Business Standard1 month ago
Business Standard

Aurobindo Pharma consolidated net profit rises 28.98% in the September 2017 quarter

Sales rise 17.25% to Rs 4354.18 crore Net profit of Aurobindo Pharma rose 28.98% to Rs 781.15 crore in the quarter ended September 2017 as against Rs 605.64 crore during the previous quarter ended September 2016. Sales rose 17.25% to Rs 4354.18 crore in the ...
 Business Standard1 month ago Aurobindo Pharma standalone net profit rises 79.57% in the September 2017 quarter  Business Standard1 month ago
Money Control

Market Update: Cipla gains over 3%; Axis Bank hits 52-week high, Bharti Airtel most active

CNX Pharma gained close to 1 percent led by Cipla, Sun Pharma and Aurobindo Pharma while Bharti Airtel, Axis Bank, Lupin, Yes Bank and Reliance Industries were the most active stocks.
 Money Control1 month ago Market update: Pharma stocks rally as Divis zooms over 16%; ICICI hits new 52-week high  Money Control1 month ago
Money Control

Nifty likely to open gap down with support at 10300; buy Aurobindo Pharma, sell PVR: Prakash Gaba

According to Technical Analyst Prakash Gaba of prakashgaba.com, the trend is still up and the next logical target is 10585 as long as 10260 holds. The crucial support for the Nifty is at 10300-10260 and the resistance is at 10410-10585. Bank Nifty on the ...
 Money Control2 weeks ago
Business Standard

Aurobindo looks for inorganic growth prospects in East Europe

Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market penetration and to secure newer technologies.Apart from acquisitions, the company is also keen to expand its product ...
 Business Standard3 weeks ago Aurobindo Pharma looks for inorganic growth prospects in East Europe  Business Standard3 weeks ago
Money Control

Buy Aurobindo Pharma; target of Rs 1030: Centrum

Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 10, 2017.
 Money Control3 weeks ago
Business Standard

Traffic restricted on over 12 roads till 11.30 am for Delhi Half Marathon

Traffic will be diverted from 22 points, including Madarasa T Point, Lodhi Road-MaxMuller crossing, Aurobindo Chowk, Motilal Nehru Marg, Mualana Azad-Janpath crossing, C- Hexagon-Ashoka Road Press Trust of India | New Delhi Last Updated at November 19, 2017 ...
 Business Standard4 weeks ago
Money Today

Price-fixing allegations, a new worry to deal with for some leading Indian pharma companies in the US

The list includes names of some of India's leading pharmaceutical companies like Sun Pharma, Dr Reddy's, Glenmark and Aurobindo. Here is the component that concerns Indian companies: The note, released on Tuesday, October 31st, says: "Previously, the lawsuit ...
 Money Today1 month ago Pharma shares in focus; Sun Pharma gains 4% in intra-day deals  Business Standard1 month ago Fund managers take value calls on pharma  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less